Kairos Ventures, a Los Angeles, CA-based early stage venture capital firm investing in physical and life sciences, closed its third fund, at $58M.
Fund III has made 27 investments in companies such as:
- Vivodyne, a bioengineering company creating fully-vascularized human organoids (“organs-on-chip”) and can deploy them in fully automated instruments conducting thousands of experiments at a time;
- PteroDynamics, an aircraft design and manufacturing company that has developed and patented a unique drone with folding airplane wings; and
- Linnaeus, a development stage biotech company engaged in studying and developing treatments for cancer using the signaling from the female sex hormone as a protection against cancer.
The remaining funds will be primarily used to support existing investments.
Founded in 2015 by Jim Demetriades, Kairos Ventures works closely with the world’s top patent producing universities and research institutions to identify and support the commercialization of transformative discoveries into sustainable and successful businesses. Since its inception, the firm has invested in over 55 companies, working side-by-side with Nobel Prize and Lasker Award winners, engineers and entrepreneurs to help them realize their full scientific and business potential.
FinSMEs
13/06/2022